Rating History for Zynerba Pharmaceuticals (ZYNE) by Canaccord
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/16/2023 | Sumant Kulkarni | Downgrade | Hold (Buy) |
1.11 (10.00) |
1.35 (1.30) |
-3.7% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/16/2023 | Sumant Kulkarni | Downgrade | Hold (Buy) |
1.11 (10.00) |
1.35 (1.30) |
-3.7% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||